Dr Dalia Dawoud

 

Dalia is a Research Officer working in Professor Dyfrig Hughes’ group. She is currently working on the SYCAMORE Trial (an HTA funded RCT) which examines the clinical effectiveness, safety and cost-effectiveness of Adalimumab in combination with Methotrexate for the treatment of Juvenile Idiopathic Arthritis Associated Uveitis.  She is also working on a review of NICE TAs of cancer drugs and has previously been responsible for reviewing the economic evidence submitted by pharmaceutical companies to the All Wales Medicines Strategy Group (AWMSG).

Dalia has a BSc in Pharmacy and a PhD in Pharmacy Practice and Policy. Her research interests cover a wide spectrum of pharmaceutical research including pharmaco-economics, clinical pharmacy practice and policy, prescribing and medicines utilisation.

She is an editorial board member for the Journal of Research in Social and Administrative Pharmacy and a reviewer for ISPOR conference and Value in Health Regional Issues journal.

 

Selected publications:

  • Ridyard C., Dawoud D., Hughes D. (2013) A systematic review of patient preferences for subcutaneous medications. ISPOR 16th Annual European Congress, Dublin, Ireland.

  • Dawoud DM, Soliman AM, Alhyas L, Amin MEK, Hussein M, Mohamed O. (2013) Translation and cultural adaptation of the SF-6D questionnaire for use in Arabic-speaking countries. ISPOR 16th Annual European Congress, Dublin, Ireland.

  • Dawoud D. (2013) Lack of Transparency needs to change. Pharmaceutical Journal, 290 (23 Feb):200

  • Dawoud D. (2013) Time for more focus on pharmacoeconomics. Pharmaceutical Journal, 291 (6 July):11.

  • Petkova, H., Dawoud, D., McCrone, P. and Higginson, I. (2012) Projections of Healthcare Costs in the Last Year of Life for Older Cancer Patients in European Union Member States (2008-2030).  2012; Journal of Epidemiology and Community Health. 66: A9

  • Hsia, Y., Dawoud, D., Sutcliffe, A., Viner, R., Kinra, S. and Wong, I. (2012) Unlicensed use of metformin in children and adolescents in the UK. British Journal of Clinical Pharmacology, 73(1):135-139.